White House Press Secretary Jen Psaki (Photo: Chip Somodevilla/Getty Images)
The United States plans to ship about 60 million doses of a domestically-made coronavirus vaccine overseas, as soon as it clears federal safety reviews.
White House Press Secretary Jen Psaki told reporters on Monday that the government is "looking at options to share American-made AstraZeneca vaccine doses during the next few months".
The batch includes a stockpile of about 10 million doses, while the remaining vaccines will be manufactured in May and June. The vaccines will be shipped overseas after the US Food and Drug Administration confirms their product quality.
Psaki said there was no need to use the AstraZeneca vaccine in the US over the next few months.
She noted that three other vaccines currently being used for inoculations across the country are available in large quantities.
She added that the AstraZeneca vaccine is not authorized for use in the US.
People aged 16 or over are now eligible for vaccines in the US. As of Monday, 28.9 percent of the US population had completed their inoculations.
Calls for fair vaccine distribution are growing in other parts of the world, as many countries are left without access to necessary doses.
Referring to which countries will receive the vaccine, Psaki said the US government is "in the planning process at this point of time." Last month, she told reporters that the government is considering shipping vaccines to Mexico and Canada.